MeiraGTx Holdings (MGTX) Gross Profit (2024 - 2025)
MeiraGTx Holdings posted quarterly Gross Profit of $74.9 million for Q4 2025, up 681.39% year-on-year from $9.6 million in Q4 2024, and up 77104.12% on a QoQ basis from $97000.0 in Q3 2025.
MeiraGTx Holdings (MGTX) has 2 years of Gross Profit data on file, last reported at $74.9 million in Q4 2025.
- For the quarter ending Q4 2025, Gross Profit rose 681.39% year-over-year to $74.9 million; the trailing twelve-month figure through Dec 2025 stood at $85.6 million (changed N/A YoY), and the FY2025 full-year result was $76.5 million, up 706.79% from the prior year.
- Gross Profit for Q4 2025 stood at $74.9 million, up from $97000.0 in the prior quarter.
- Across five years, Gross Profit topped out at $74.9 million in Q4 2025 and bottomed at -$1.1 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 74.89 Mn |
| Dec 31, 2025 | 74.89 Mn |
| Sep 30, 2025 | 97,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Jun 30, 2025 | 1.02 Mn |
| Jun 30, 2025 | 1.02 Mn |
| Dec 31, 2024 | 9.58 Mn |
| Dec 31, 2024 | 9.58 Mn |
| Sep 30, 2024 | -1.08 Mn |
| Sep 30, 2024 | -1.08 Mn |